U.S. flag

An official website of the United States government

GRCh37/hg19 12q14.3-21.1(chr12:65251705-75263379)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 22, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001537907.4

Allele description [Variation Report for GRCh37/hg19 12q14.3-21.1(chr12:65251705-75263379)x1]

GRCh37/hg19 12q14.3-21.1(chr12:65251705-75263379)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
12q14.3-21.1
Genomic location:
Chr12: 65251705 - 75263379 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 12q14.3-21.1(chr12:65251705-75263379)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV001754835Illumina Laboratory Services, Illumina
    criteria provided, single submitter

    (ICSL CNVClassificationCriteria Jul2020Prior)
    Pathogenic
    (May 22, 2020)
    unknownclinical testing

    PubMed (7)
    [See all records that cite these PMIDs]

    Citation Link

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.

    Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP.

    Am J Hum Genet. 2009 Apr;84(4):524-33. doi: 10.1016/j.ajhg.2009.03.010. Epub 2009 Apr 2.

    PubMed [citation]
    PMID:
    19344873
    PMCID:
    PMC2667985

    Nasal speech and hypothyroidism are common hallmarks of 12q15 microdeletions.

    Vergult S, Krgovic D, Loeys B, Lyonnet S, Liedén A, Anderlid BM, Sharkey F, Joss S, Mortier G, Menten B.

    Eur J Hum Genet. 2011 Oct;19(10):1032-7. doi: 10.1038/ejhg.2011.67. Epub 2011 Apr 20.

    PubMed [citation]
    PMID:
    21505450
    PMCID:
    PMC3190250
    See all PubMed Citations (7)

    Details of each submission

    From Illumina Laboratory Services, Illumina, SCV001754835.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (7)

    Description

    This CNV is a 10.0 Mb deletion of 12q14.3-q21.1 on chromosome 12 (seq[GRCh37]del(12)(q14.3q21.1); chr12:g.65251705_75263379del), found in a de novo state. This loss encompasses over 65 genes and includes most of band 12q14.3, all of band 12q15 and most of band 12q21.1. The proximal breakpoint lies within the TBC1D30 gene and the distal breakpoint lies between the ATXN7L3B gene, which is encompassed by this event, and the KCNC2 gene, which is not encompassed by this event. Interstitial 12q deletions are rare and, in most cases, breakpoints are unique and non-recurrent. However, several partially overlapping and smaller losses falling within the boundaries of this event have been reported in individuals with phenotypes including prenatal and postnatal growth deficiency, neurodevelopmental disorders and variable congenital anomalies (Firth et al. 2009; Rehm et al. 2015). Smaller de novo and familial 12q14 deletions including LEMD3, associated with autosomal dominant osteopoikilosis and HMGA2, implicated in growth, have been reported in individuals with prenatal-onset growth deficiency, failure to thrive in early childhood, proportionate short stature, osteopoikilosis, learning disabilities, mild intellectual disability and dysmorphic features often described as Russell-Silver like (Fischetto et al. 2017; Heldt et al. 2018). Vergult et al. (2011) described three unique but overlapping deletions impacting band 12q15 and report developmental delay, nasal speech and hypothyroidism as core features associated with deletions of this region. Additional features in these individuals included variable dysmorphic features, thin habitus with slender fingers and toes, hypoplastic nails, mild scoliosis and, in one individual, a history of acute lymphoblastic leukemia (2011). Haploinsufficiency of CNOT2 may be a significant contributor to this phenotype, although other genes with evidence supporting an intolerance to loss of function are present in this interval (Uehara et al. 2019). Rare events which also extend into 12q21.1 are also rarely described and are associated with variable phenotypes (Schluth et al. 2008). This interval also includes WIF1, which has been reported as a candidate gene for a Nail-Patella like syndrome in a multi-generational family (Jones et al. 2017). Overlapping losses are not reported in control individuals. Based on the collective evidence, this CNV is classified as pathogenic.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Oct 14, 2023